Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5431)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2013 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kanda T, Kato K, Tsubota A, Takada N, Nishino T, Mikami S, Miyamura T, Maruoka D, Wu S, Nakamoto S, Arai M, Fujiwara K, Imazeki F, Yokosuka O. Platelet count and sustained virological response in hepatitis C treatment. World J Hepatol 2013; 5(4): 182-188 [PMID: 23671722 DOI: 10.4254/wjh.v5.i4.182] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v5/i4/182.htm |
| Number | Citing Articles |
| 1 |
Hanan H. Rizk, Nadia M. Hamdy, Nadia L. Al-Ansari, Hala O. El-Mesallamy, Ming-Lung Yu. Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4. PLOS ONE 2016; 11(4): e0153895 doi: 10.1371/journal.pone.0153895
|
| 2 |
Silvia Odolini, Silvia Amadasi, Carlo Cerini, Mariarosaria Giralda, Paola Nasta, Francesco Castelli. Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV. BMC Infectious Diseases 2014; 14(S5) doi: 10.1186/1471-2334-14-S5-S4
|
| 3 |
Ashraf A. Tabll, Mamdouh S. Afifi, Abd-Allah S. El-Etrawy, Salah M. El-Kousy, Martina Smolic, Yasmine S. El Abd. CXCL9 chemokine level is associated with spontaneous clearance and sustained virological response in Egyptian Chronic Hepatitis C patients receiving direct acting antivirals. Human Antibodies 2020; 28(2): 141 doi: 10.3233/HAB-190400
|
| 4 |
Kanda Tatsuo, Yokosuka Osamu, Omata Masao. Antiviral therapy for “difficult-to-treat” hepatitis C virus-infected patients. Chinese Medical Journal 2013; 126(23): 4568 doi: 10.3760/cma.j.issn.0366-6999.20131127
|
| 5 |
Tatsuo Kanda, Shingo Nakamoto, Shuang Wu, Osamu Yokosuka. Role of <italic>IL28B</italic> genotype in older hepatitis C virus-infected patients. World Journal of Immunology 2013; 3(3): 54-61 doi: 10.5411/wji.v3.i3.54
|
| 6 |
Baek Gyu Jun, Eui Ju Park, Woong Cheul Lee, Jae Young Jang, Soung Won Jeong, Young Don Kim, Gab Jin Cheon, Young Sin Cho, Sae Hwan Lee, Hong Soo Kim, Yun Nah Lee, Sang Gyune Kim, Young Seok Kim, Boo Sung Kim. Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C. The Korean Journal of Internal Medicine 2019; 34(5): 989 doi: 10.3904/kjim.2017.322
|
| 7 |
Samar Kamal Darweesh. Pathology Predictors of Response to Combined Therapy of Chronic HCV Patients; Is it Applicable in the DAA Era?. Gastroenterology & Hepatology: Open Access 2016; 5(8) doi: 10.15406/ghoa.2016.05.00176
|
| 8 |
Rabab Fouad, Khaled Zachariah, Marwa Khairy, Mervat Khorshied, Wafaa Ezzat, Marwa M. Sheta, Ahmed Heiba. Single Nucleotiders760370Polymorphism at the Main Ribavirin Transporter Gene Detection by PCR-RFLP Assay Compared with the TaqMan Assay and Its Relation to Sustained Virological Response in Chronic HCV Patients Treated with Pegylated Interferon–Ribavirin Therapy. Journal of Interferon & Cytokine Research 2017; 37(2): 90 doi: 10.1089/jir.2016.0099
|
| 9 |
J. M. Boone, W. Cui. Spectrum of bone marrow morphologic findings in hepatitis C patients with and without prior liver transplantation. International Journal of Laboratory Hematology 2016; 38(6): 694 doi: 10.1111/ijlh.12559
|